Differential Expression of a Ligand Induced Binding Site (LIBS) by GPIIb-IIIa Ligand Recognition Peptides and Parenteral Antagonists

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Thrombosis and Haemostasis

• Publication date

  2000-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1055/s-0037-1614176PMID 11154119
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• von Willebrand Factor

  2002cited by this paper
• Monoclonal Antibodies to Ligand-occupied Conformers of Integrin aIIbP 3 ( Glycoprotein IIb-IIIa ) Alter Receptor Affinity , Specificity , and Function *

  2001cited by this paper
• Potential non-glycoprotein IIb/IIIa effects of abciximab.

  1999cited by this paper
• Eptifibatide: a review of its use in patients with acute coronary syndromes and/or undergoing percutaneous coronary intervention.

  1999cited by this paper
• Induction of fibrinogen binding and platelet aggregation as a potential intrinsic property of various glycoprotein IIb/IIIa (alphaIIbbeta3) inhibitors.

  1998cited by this paper
• Inhibition of Fibrinogen Binding and Surface Recruitment of GpIIb/IIIa as Dose-Dependent Effects of the RGD-Mimetic MK-852

  1998cited by this paper
• Induction of Fibrinogen Binding and Platelet Aggregation as a Potential Intrinsic Property of Various Glycoprotein IIb/IIIa (IIbβ3) Inhibitors

  1998cited by this paper
• Inhibition of platelet glycoprotein IIb/IIIa with eptifibatide in patients with acute coronary syndromes.

  1998cited by this paper
• A recombinant soluble form of the integrin alpha IIb beta 3 (GPIIb-IIIa) assumes an active, ligand-binding conformation and is recognized by GPIIb-IIIa-specific monoclonal, allo-, auto-, and drug-dependent platelet antibodies.

  1998cited by this paper
• Inhibition of the platelet glycoprotein IIb/IIIa receptor with tirofiban in unstable angina and non-Q-wave myocardial infarction.

  1998cited by this paper
• von Willebrand factor.

  1997cited by this paper
• Randomised placebo-controlled trial of abciximab before and during coronary intervention in refractory unstable angina: the CAPTURE Study.

  1997cited by this paper
• 7E3 monoclonal antibody directed against the platelet glycoprotein IIb/IIIa cross-reacts with the leukocyte integrin Mac-1 and blocks adhesion to fibrinogen and ICAM-1.

  1997cited by this paper
• Effects of platelet glycoprotein IIb/IIIa blockade with tirofiban on adverse cardiac events in patients with unstable angina or acute myocardial infarction undergoing coronary angioplasty. The RESTORE Investigators. Randomized Efficacy Study of Tirofiban for Outcomes and REstenosis.

  1997cited by this paper
• Randomised placebo-controlled trial of effect of eptifibatide on complications of percutaneous coronary intervention: IMPACT-II. Integrilin to Minimise Platelet Aggregation and Coronary Thrombosis-II.

  1997cited by this paper
• Impaired platelet aggregation andsustained bleeding inmicelacking thefibrinogen motifbound byintegrin alIb13

  1996cited by this paper
• Selective induction of a glycoprotein IIIa ligand-induced binding site by fibrinogen and von Willebrand factor.

  1996cited by this paper
• Impaired platelet aggregation and sustained bleeding in mice lacking the fibrinogen motif bound by integrin alpha IIb beta 3.

  1996cited by this paper
• Blockade of platelet GPIIb/IIIa receptors as an antithrombotic strategy.

  1995cited by this paper
• Characterization of Adhesion of Resting and Stimulated Platelets to Fibrinogen and Its Fragments

  1994cited by this paper
• Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty.

  1994cited by this paper
• Characterization of adhesion of resting and stimulated platelets to fibrinogen and its fragments.

  1993cited by this paper
• Conformational modulation of purified glycoprotein (GP) IIb-IIIa allows proteolytic generation of active fragments from either active or inactive GPIIb-IIIa.

  1992cited by this paper
• Activation-independent exposure of the GPIIb-IIIa fibrinogen receptor.

  1991cited by this paper
• Monoclonal antibodies to ligand-occupied conformers of integrin alpha IIb beta 3 (glycoprotein IIb-IIIa) alter receptor affinity, specificity, and function.

  1991influential reference
• GPIIb-IIIa: the responsive integrin.

  1991cited by this paper
• Platelet Adhesion to Extracellular Matrices of Cultured Cells

  1991cited by this paper
• A conformation-dependent epitope of human platelet glycoprotein IIIa.

  1990influential reference
• Selective inhibition of integrin function by antibodies specific for ligand-occupied receptor conformers.

  1990influential reference
• Ca2+-dependent binding of a synthetic Arg-Gly-Asp (RGD) peptide to a single site on the purified platelet glycoprotein IIb-IIIa complex.

  1989influential reference
• Chemical cross-linking of arginyl-glycyl-aspartic acid peptides to an adhesion receptor on platelets.

  1988cited by this paper
• New perspectives in cell adhesion: RGD and integrins.

  1987cited by this paper
• Competition for related but nonidentical binding sites on the glycoprotein IIb-IIIa complex by peptides derived from platelet adhesive proteins.

  1987cited by this paper
• Synthetic peptides derived from fibrinogen and fibronectin change the conformation of purified platelet glycoprotein IIb-IIIa.

  1987cited by this paper
• Evidence that arginyl-glycyl-aspartate peptides and fibrinogen gamma chain peptides share a common binding site on platelets.

  1987cited by this paper
• Arg-Gly-Asp: a versatile cell recognition signal.

  1986cited by this paper
• The role of platelet membrane glycoproteins Ib and IIb‐IIIa in platelet adherence to human artery subendothelium

  1986cited by this paper
• A method for purifying the platelet membrane glycoprotein IIb-IIIa complex.

  1985cited by this paper
• Evidence that three adhesive proteins interact with a common recognition site on activated platelets.

  1984cited by this paper
• Platelet-collagen adhesion: inhibition by a monoclonal antibody that binds glycoprotein IIb

  1984influential reference
• Platelet receptor recognition site on human fibrinogen. Synthesis and structure-function relationship of peptides corresponding to the carboxy-terminal segment of the gamma chain.

  1984cited by this paper
• A murine monoclonal antibody that completely blocks the binding of fibrinogen to platelets produces a thrombasthenic-like state in normal platelets and binds to glycoproteins IIb and/or IIIa.

  1983cited by this paper
• Basic Statistics for the Behavioral Sciences@@@Biostatistics: A Foundation for Analysis in the Health Sciences

  1980cited by this paper
• Interaction of fibrinogen with its platelet receptor as part of a multistep reaction in ADP-induced platelet aggregation.

  1980cited by this paper
• Exposure of platelet fibrinogen receptors by ADP and epinephrine.

  1979cited by this paper
• The hemostatic plug.

  1977cited by this paper

• Complications and Management of Eptifibatide-Induced Thrombocytopenia

  2021cites this paper
• Immobilisation of an anti-platelet adhesion and anti-thrombotic drug (EP224283) on polydopamine coated vascular stent promoting anti-thrombogenic properties.

  2020cites this paper
• Novel Pure αVβ3 Integrin Antagonists That Do Not Induce Receptor Extension, Prime the Receptor, or Enhance Angiogenesis at Low Concentrations

  2019cites this paper
• Drug-Induced Thrombocytopenia: Pathogenesis, Diagnosis and Management

  2017cites this paper
• Targeting Integrin and Integrin Signaling in Treating Thrombosis

  2015cites this paper
• Eptifibatide-induced acute profound thrombocytopenia: a case report

  2014cites this paper
• C560Rβ3 caused platelet integrin αIIbβ3 to bind fibrinogen continuously, but resulted in a severe bleeding syndrome and increased murine mortality

  2013cites this paper
• Computer-aided design of novel antithrombotic agents

  2013cites this paper
• Drug-induced immune thrombocytopenia.

  2013cites this paper
• associated with antibodies specific for ligand-occupied GPIIb/IIIa Acute thrombocytopenia after treatment with tirofiban or eptifibatide is

  2013cites this paper
• GPIIb/IIIa inhibitors: From bench to bedside and back to bench again

  2012cites this paper
• Structure-Guided Design of a High-Affinity Platelet Integrin αIIbβ3 Receptor Antagonist That Disrupts Mg2+ Binding to the MIDAS

  2012cites this paper
• Antibodies causing thrombocytopenia in patients treated with RGD-mimetic platelet inhibitors recognize ligand-specific conformers of αIIb/β3 integrin.

  2012cites this paper
• and its complex with an

  2011cites this paper
• Intact αIIbβ3 Integrin Is Extended after Activation as Measured by Solution X-ray Scattering and Electron Microscopy*

  2011cites this paper
• Closed headpiece of integrin αIIbβ3 and its complex with an αIIbβ3-specific antagonist that does not induce opening.

  2010cites this paper
• Platelet perturbations in diabetes: implications for cardiovascular disease risk and treatment

  2009cites this paper
• Application of high-throughput screening to identify a novel (cid:1) IIb-specific small-molecule inhibitor of (cid:1) IIb (cid:2) 3-mediated platelet interaction with fibrinogen

  2008cites this paper
• Eptifibatide-induced thrombocytopenia

  2008cites this paper
• Application of high-throughput screening to identify a novel alphaIIb-specific small- molecule inhibitor of alphaIIbbeta3-mediated platelet interaction with fibrinogen.

  2008cites this paper
• THE GPIIB/IIIA ANTAGONIST ABCIXIMAB FOR ACUTE PERCUTANEOUS CORONARY INTERVENTION

  2007cites this paper
• Target validation in drug discovery.

  2007cites this paper
• Eptifibatide-induced thrombocytopenia and thrombosis

  2006cites this paper
• Therapeutic expression of the platelet-specific integrin, αIIbβ3, in a murine model for Glanzmann thrombasthenia

  2005cites this paper
• Procoagulant activity of adherent platelets

  2005cites this paper
• The Effect of Glycoprotein IIIa PIA1/A2 Polymorphism on the PFA-100 Response to GP IIbIIIa Receptor Inhibitors—The Importance of Anticoagulants Used

  2005cites this paper
• In vivo platelet redistribution and acute transient thrombocytopenia after eptifibatide injection in baboons.

  2005cites this paper
• Therapeutic expression of the platelet-specific integrin, alphaIIbbeta3, in a murine model for Glanzmann thrombasthenia.

  2005cites this paper
• Pharmacodynamics of GPIIb-IIIa Receptor Blockade

  2005cites this paper
• Reversibility versus Persistence of GPIIb/IIIa Blocker-Induced Conformational Change of GPIIb/IIIa (αIIbβ3, CD41/CD61)

  2004cites this paper
• Delayed immunologic thrombocytopenia induced by abciximab

  2004cites this paper
• Oral GPIIb/IIIa antagonists: what went wrong?

  2004cites this paper
• Comparison of Shear Stress–Induced Platelet Microparticle Formation and Phosphatidylserine Expression in Presence of &agr;IIb&bgr;3 Antagonists

  2003cites this paper
• Platelet Function and Immune Response

  2003cites this paper
• Tirofiban Blocks Platelet Adhesion to Fibrin with Minimal Perturbation of GpIIb/IIIa Structure

  2002cites this paper
• MK-383 (Tirofiban) induces a GPIIb/IIIa receptor conformation which differs from the resting and activated receptor

  2002cites this paper
• Acute Thrombocytopenia in Patients Treated with the Oral Glycoprotein IIb/IIIa Inhibitors Xemilofiban and Orbofiban: Evidence for an Immune Etiology

  2002cites this paper
• Glycoprotein IIb/IIIa antagonists - from bench to practice

  2002cites this paper
• Acute thrombocytopenia after treatment with tirofiban or eptifibatide is associated with antibodies specific for ligand-occupied GPIIb/IIIa.

  2002cites this paper
• Inhibition of Shear-Stress-Induced Platelet Aggregation and Phosphotyrosine Signaling by GPIIb–IIIa Antagonists

  2002cites this paper
• Paradoxical Platelet Activation Was not Observed on Dissociation of Abciximab from GPIIb-IIIa Complexes

  2002cites this paper
• Anti-GPIIb/IIIa Drugs: Current Strategies and Future Directions

  2001cites this paper
• Glycoprotein IIb-IIIa in Platelet Aggregation and Acute Arterial Thrombosis

  1999cites this paper